Article PDF
Rights and permissions
About this article
Cite this article
USCAP 2022 Abstracts: Autopsy and Forensics (1-23). Lab Invest 102 (Suppl 1), 1–23 (2022). https://doi.org/10.1038/s41374-022-00745-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41374-022-00745-3
This article is cited by
-
Siglec 15 as a biomarker or a druggable molecule for non-small cell lung cancer
Journal of Cancer Research and Clinical Oncology (2023)